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Abstract
Previous literature has established that increases in prescription opioid misuse has
resulted in similar increases in injection drug use (IDU), collectively referred to as the
“opioid epidemic” in the US. Due to this surge in IDU, incidence of Hepatitis C (HCV)
and Human Immunodeficiency Virus (HIV) are on the rise in many regions. Research
conducted in Canada and elsewhere has supported the use of Safe Injection Facilities
(SIFs) and Needle Syringe Programs (NSPs) to mollify disease incidence, but only NSPs
are operating in the US despite SIFs having been in use in Canada for several decades. As
little research has been conducted in the US about where SIFs could be of benefit, we
employ an analytical model to estimate the value of a hypothetical SIF in Kent County,
Michigan (MI) using local surveillance data. Addition of such a facility was found to
reduce HCV incidence by 7 cases / year, in addition to decreasing HIV incidence by 5%.

Background
Treatment for opioid use disorder occupies a precarious space within the
American legal, medical, and cultural frameworks. In 1971, the “War on Drugs” began in
earnest, although another three years had passed before the Narcotic Addict Treatment
Act was signed into law, which established the legality of methadone clinics. Methadone
(although commonly mistaken for the street drug “meth”, which is an entirely different
substance whose full name is methamphetamine) is in many ways an ideal drug from
treating opioid addiction, as its properties allow for the abatement of withdrawal
symptoms without the euphoric effects of heroin or morphine, which can allow users to
maintain steady employment and begin rebuilding the social damages caused by
addiction. Results of this approach were encouraging, but less than two decades later, an
unrelated report by the American Pain Society advocated that pain was determined to be
the “fifth vital sign” in medicine. This report argued that physicians to minimize patient
suffering as much as possible— often relying on opioids to do so1. This effort was well-

1 “The 5th Vital Sign and America’s Painkiller Epidemic.” 2016. The University of Arizona Health

Sciences. April 1, 2016. https://uahs.arizona.edu/blog/2016-04-02/5th-vital-sign-andamerica%E2%80%99s-painkiller-epidemic.
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intentioned but had side effect of vastly increasing the number of opioids in circulation,
becoming what many consider to be a prominent cause for today’s current opioid
epidemic.
Because of the variance in patient needs and circumstances, it stands to reason
that a wider array of therapeutic options can result in better individualized treatment and
outcomes; and indeed congress and the U.S. Food and Drug Administration (FDA) has
since approved other drugs for therapeutic use: two such being Buprenorphine and
Naltrexone. Buprenorphine can only be prescribed in a primary care setting, and while as
an “agonist-antagonist” it has proven effective in achieving abstinence in a short period
of time, there remain concerns about longer term mortality rates that may be due to
patient tolerance discrepancies2. Naltrexone, on the other hand, is available as a depot
injection and as such isn’t subject to the adherence or overdose concerns of oral tablets,
but has limited effectiveness otherwise3.
While it is true that these drugs have unique profiles and can be tailored to fit
specific patient needs, the limitations of an incongruent approach to the broader social,
economic, and legal context of the opioid crisis has been exacerbated by the alarming
growth of the epidemic. This calls for stronger efforts to destigmatize addiction in both a
social and clinical context in order to improve patient retention and adherence to all
intervention methods. It is for this reason that safe injection facilities (SIFs) have great
potential. Put plainly, SIFs are clinics that are staffed by licensed physicians and nursing
staff where opioid users can go, without legal consequence, to inject the drugs they have
pre-obtained prior to visiting the SIF. The benefit of this arrangement is derived from the
provision of clean injection materials, best-practices education from the clinical staff on
site, emergency care that is immediately available as needed, as well as stigma-free
patient access. In addition, these facilities provide an access point to more robust
cessation programs that is favorable to many patients because they are already typically
2 Luis Sordo et al., “Mortality Risk during and after Opioid Substitution Treatment: Systematic

Review and Meta-Analysis of Cohort Studies,” The BMJ 357 (April 26, 2017),
https://doi.org/10.1136/bmj.j1550.
3 Tanum L et al., “Effectiveness of Injectable Extended-Release Naltrexone vs Daily BuprenorphineNaloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial,” JAMA Psychiatry 74,
no. 12 (December 1, 2017): 1197–1205, https://doi.org/10.1001/jamapsychiatry.2017.3206.
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familiar with the facility and care experience at that SIF. Although legally no such
facilities currently exist in the United States, current data from the Insite (SIF) facility in
Vancouver, British Columbia suggests 88 fewer deaths per 100,000 person years, as well
as a net public savings in spending4. Analytical models for Insite have determined that
similar benefits are feasible with a facility in the US: hypothetical facilities in Baltimore,
San Francisco, and elsewhere have proven to improve patient outcomes while remaining
financially solvent. Results such as these provide the basis to argue that SIFs give
physicians an additional degree of control in the overall treatment pathway, allowing for
various risk factors to be mitigated via proactive efforts that compliment existing
cessation efforts.

Significance
Although the benefit of SIFs have been established in some major metropolitan
areas, much less research has been conducted in less densely populated regions where the
need is either not as great or otherwise not as concentrated geospatially, especially in the
United States where there are legal barriers obstructing the short term value of this
information. As such, the estimated impact of a SIF in an area like the Kent County is
largely an unknown. However, the broader opioid epidemic in the US is that the problem
is still worsening. In 2017 67.8% of 70,237 overdose deaths were due to opioids. About
15,000 were due to drug overdoses involving heroin— with current information from the
Centers for Disease Control (CDC) showing some 400,000 deaths due to opioid overdose
from 1999-2017, making it the number one form of accidental death in the country5.
Figures as dire as these call for greater investment within existing healthcare structures,
but also merit the consideration of feasible alternatives.
To this end, although epidemiological methods of measuring needle / syringe
programs (NSPs) have been around for a few decades, more recent studies have built

4 Jennifer Ng, Christy Sutherland, and Michael R. Kolber, “Does Evidence Support Supervised

Injection Sites?,” Canadian Family Physician 63, no. 11 (November 2017): 866.
5 Lawrence Scholl, “Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017,”
MMWR. Morbidity and Mortality Weekly Report 67 (2019),
https://doi.org/10.15585/mmwr.mm6751521e1.
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upon Kaplan’s “Circulation Theory of Needle Exchange” in order to assess the effect of
SIFs in a manner that also takes into consideration the impact of NSPs operating within
the same communities67. Although the primary objective of this research is to determine
the impact of a SIF in Kent County, MI based on a defined set of variables, a secondary
objective will include examination of the model itself with an intent to identify potential
modifications to the model itself, or via localized data collection methods in order to
contribute to the discussion of how this model is applied in future research.
In addition, data necessary for this model to be generalizable to a local area is not
readily available at an individual location, municipal or county level, and collating data
from state or national health agencies, and existing needle exchange facilities would help
to better estimate the severity of the problem in this specific region. In the same way,
investigation in this sector would highlight what information is not commonly collected
but could be in order to improve future research on health outcomes that would also
likely be impacted by a SIF or other similar interventions.
While mitigating negative health outcomes is of great value to the patient
demographic in question, it bears reminding that the treatment of these conditions are
also associated with significant economic costs, which are at least in part borne by the
general taxbase. The calculated impacts can be weighed against the estimated costs of
constructing and operating this sort of facility to provide predictive and tangible
information that may help inform future policy decisions. This information would help
illuminate the conditions under which opening a SIF is economically solvent and a viable
taxpayer investment using commonly collected health statistics.

Methods
As stated, Kaplan’s “circulation theory of needle exchange” takes into
consideration a variety of behaviors common amongst people who use drugs (PWID)
which are then employed to estimate a change in incidence within the at-risk
AIDS (London, England) 8,
no. 5 (May 1994): 567–74.
7 Steven D. Pinkerton, “Is Vancouver Canada’s Supervised Injection Facility Cost-Saving?,” Addiction
105, no. 8 (2010): 1429–36, https://doi.org/10.1111/j.1360-0443.2010.02977.x.
6 E. H. Kaplan and R. Heimer, “A Circulation Theory of Needle Exchange,”
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subpopulation of PWID. Collecting and analyzing reliable information on each
contributing variable presents numerous challenges in and of itself— while many of these
variables are ascertained or extrapolated via localized health statistics, others can only be
derived through direct communication within the PWID community itself, thus
encouraging the use of large scale statistics collecting from the CDC and others. The
illegal status of PWID is a significant driver in behavior for obvious reasons, but also
adds a great deal of ethical concerns that must be adhered to for the sake of anonymity
and privacy as well as to obtain responses demonstrating limited bias, or are reflective of
real life. The model is given as:

Disease Incidence Associated with Needle Sharing at a Given Rate:

𝐼𝐼𝐼𝐼 /𝐼𝐼𝐶𝑉 = 𝐼𝐼𝐼𝐼[1 − (1 − 𝐼𝐼)𝐼 ]
Variable
i

Value
HIV - 93.6093%
HCV - 38.2%

Description
Proportion of PWID HIV(-) / HCV(-)

N

978,621

Number of needles in circulation

s

8%

Rate of needle sharing

d

17%

Percentage of unclean needles

q

t

M

HIV - 6.39075%
HCV - 61.8%
HIV - 0.63%
HCV - 0.57%
1.3125

Proportion of PWID HIV(+) / HCV(+)

Probability of HIV / HCV infection from a single injection

Number of sharing partners
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The “rate of needle sharing” is calculated as a “before or after intervention” by a
separate sub equation given below:

Change in the Rate of Needle Sharing:

(𝐼 − 𝐼) + (1 − 𝐼)𝐼
𝐼𝐼𝐼𝐼𝐼 = 𝐼𝐼𝐼𝐼
𝐼
Variable

Value

Description

n

70%

SIF client reduction in needle sharing

N

7,301

Number of unique, annual SIF clients

T

16,863

PWID Population (lifetime)

PWID Population
Definition : Estimated size of the PWID community in Kent County, Michigan
Selected Figure : 16,863 lifetime / 1945 prior-year

Given the legal status of PWID, it is undeniably difficult to estimate the size of
the PWID population. Methods used in the past include “capture-and-release”, the
multiplier method, and survey meta-analysis. Previous research employing the multiplier
method averaged several estimates of PWID numbers to determine a possible number of
PWID in metropolitan regions8. While using additional sets of information or longer
sampling periods can improve the accuracy of this approach, multiplier methods are

8 Barbara Tempalski et al., “Trends in the Population Prevalence of People Who Inject Drugs in US

Metropolitan Areas 1992–2007,” PLOS ONE 8, no. 6 (June 5, 2013): e64789,
https://doi.org/10.1371/journal.pone.0064789.
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typically subject to a large degree of variability. This is similarly true of capture-andrelease, although it should also be noted that more recent attempts using this approach,
while considered highly accurate, were used to calculate areas hit particularly hard by the
opioid epidemic and would not be generalizable in other settings9.
Emulating a method employed by the CDC to estimate the STI disease burden
amongst men who have sex with men (MSM), Lansky, et al. set about a multi-phase
process to collect usable survey data with strict exclusion criterion. Those sufficiently
homogenous for comparison generated estimates for the amount of individuals that have
injected drugs in the previous year as well at some point in their lives. 2.6% of the US
population (6,612,488 individuals) are estimated to have used injection drugs at some
point in their lives. For the past year usage was 0.30%, or 774,434 individuals― both
estimates apply to the year 201110. Contrasted to other studies, the previous year finding
was roughly half of Tempalski’s multiplier method estimate. It should be noted that as
there is no accepted standard for this estimate, it could be that either study is either
underestimating or overestimating the size of the PWID population respectively. That
said, conservative estimates for the lifetime PWID population size of Kent County at a
population of 648,594 stands at approximately 16,863 individuals using 2018 population
sizes according to this approach.

Proportion of PWID that are HIV+ / HCV+
Definition : The percentage of the Kent County PWID population that is HIV+ / HCV+
Selected Figure :
6.39075% HIV+
61.8% HCV+

9 Lawrence Scholl, “Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017,”

MMWR. Morbidity and Mortality Weekly Report 67 (2019),
https://doi.org/10.15585/mmwr.mm6751521e1.
10 Amy Lansky et al., “Estimating the Number of Persons Who Inject Drugs in the United States by
Meta-Analysis to Calculate National Rates of HIV and Hepatitis C Virus Infections,” PLoS ONE 9, no. 5
(May 19, 2014), https://doi.org/10.1371/journal.pone.0097596.
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Using 2016 data, the CDC reports that roughly 6.6% of HIV diagnoses were
attributable to IDU at a national level11. Including both MSM/PWID and PWID only, the
Michigan Department of Health and Human Services (MDHHS) reported that 11% of
HIV prevalence in Michigan attributable to IDU (including IDU/MSM), or 7% of HIV
prevalence attributable to IDU alone12. Applied to our estimate of the broader PWID
population, we estimate that roughly 6.39% (~1945 individuals) of the PWID population
in Kent County is living with HIV. A necessary caveat here is that the CDC estimates
that one in seven individuals infected with HIV are unaware, and as such this may be
underreported by roughly 15%.
With regards to HCV, the CDC reports roughly 53.1% (range: 38.1%-68.0%, 95%
CI) prevalence of HCV amongst PWID using global meta-analysis13. This rate does vary
by report, as the CDC also reported 68.6% acute cases attributable to IDU in 2016, and
67% globally14. At a more localized level, this seems to coincide with survey data
collected by the MDHHS in which 62% of those diagnosed with chronic HCV also
reported recent injection drug usage, as well as 56% of diagnosed acute cases of HCV 15.
Applying this information to the total number of cases in Kent County allows us to
estimate the number of HIV+ / HCV+ whom are PWID as follows:

11 “Statistics Overview | Statistics Center | HIV/AIDS | CDC.” 2019. April 12, 2019.

https://www.cdc.gov/hiv/statistics/overview/index.html.
12 Michigan Dept. of Health and Human Services, “Epidemiologic Profile of HIV in Michigan”, 2018.
13 Louisa Degenhardt et al., “Global Prevalence of Injecting Drug Use and Sociodemographic
Characteristics and Prevalence of HIV, HBV, and HCV in People Who Inject Drugs: A Multistage
Systematic Review,” The Lancet. Global Health 5, no. 12 (October 23, 2017): e1192–1207,
https://doi.org/10.1016/S2214-109X(17)30375-3.
14 Kimberly Page et al., “Injection Drug Use and Hepatitis C Virus Infection in Young Adult Injectors:
Using Evidence to Inform Comprehensive Prevention,” Clinical Infectious Diseases: An Official
Publication of the Infectious Diseases Society of America 57, no. Suppl 2 (August 15, 2013): S32–38,
https://doi.org/10.1093/cid/cit300.
15 Michigan Dept. of Health and Human Services, “Hepatitis B and C Annual Surveillance Report”, 2018
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Kent County HIV+ / HCV+
Total Reported (2018)
% Attributable to PWID

Amount due to

(Statewide)

PWID

1130

11%

124.3

Chronic HCV+

454

62%

281.48

Acute HCV+

11

56%

6.16

Seropositive HCV

465

61.8%

287.64

Condition

No.

HIV+

While these numbers are reliant on mathematical estimations and are therefore
inherently inexact, there is evidence that the rate of reported HCV is significantly smaller
than the true incidence when unreported cases are also considered. Reports demonstrate
anywhere from 12.30 actual cases per each single reported case up to 23 cases per every
reported, as posted by the CDC and others1617. This is partially due to the infection being
effectively asymptomatic throughout the most stages of infection up until hepatic
function is severely impaired but also because it stands to reason that PWID would be
less likely to voluntarily seek testing for legal and social reasons, increasing rates of
infection within that community.

Proportion of PWID that are HIV- / HCVDefinition : The percentage of the Kent County PWID population that is HIV- / HCVSelected Figure :
16 R. Monina Klevens et al., “Estimating Acute Viral Hepatitis Infections From Nationally Reported

Cases,” American Journal of Public Health; Washington 104, no. 3 (March 2014): 482–87.
17 Brian R. Edlin et al., “Toward a More Accurate Estimate of the Prevalence of Hepatitis C in the
United States,” Hepatology (Baltimore, Md.) 62, no. 5 (November 2015): 1353–63,
https://doi.org/10.1002/hep.27978.
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93.6093% HIV38.1419% HCV-

As specific knowledge of the number of HIV- or HCV- individuals is dependent
on the total PWID population, an exact estimate of this value is subject to the same
assumptions as those those given above. With that said, using our estimated PWID
population sizes and the calculated rates of HIV+ / HCV+ individuals, the remainder
(HIV- / HCV-) can be similarly estimated.

Kent County HIV- /
HCV- (2017)
Outcome

% of Total

HIV-

93.6093

Seronegative
HCV-

38.1419

Per-Act HIV Risk
Definition : The risk of viral transmission from a single use of a needle or syringe
previously used by another individual infected with HIV
Selected Figure : 0.63%

Given the differing biochemical characteristics of each virus, the rate of
transmission is specific to the virus itself. In addition, the specific subtype of the HIV
preeminent within any particular geographic area need also be considered for the same
reason. Reported statistics range from 0.63%-2.4%18. On the more conservative side a
18 Rebecca F Baggaley et al., “Risk of HIV-1 Transmission for Parenteral Exposure and Blood

Transfusion: A Systematic Review and Meta-Analysis:,” AIDS 20, no. 6 (April 2006): 805–12,
https://doi.org/10.1097/01.aids.0000218543.46963.6d.
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large study specific to the B-subtype was conducted in Thailand and found a per-act risk
rate of 0.63%, or roughly a 1/158 chance per needle sharing event19. This figure is also
supported by meta-analysis and has been adopted as the currently accepted CDC rate20.
Given that this 0.63% figure is sufficiently sampled, of the subtype predominant in North
America, conservative compared to other measures, and is accepted as the current
standard, it is the preferred number to use for this analysis short of having highly
localized data available or otherwise conducting a test using weighted prevelances of
each subtype.

Per-Act HCV Risk
Definition : The risk of viral transmission from a single use of a needle or syringe
previously used by another individual infected with HCV
Selected Figure : 0.57%

Accidental needlestick injuries are commonly recorded in clinical environments
as workplace accidents, and thus might act as reliable data on HCV transmission.
Available data from the CDC provides a cumulative risk of roughly 1.8% per act via
needlestick injury to health care workers. However, it should be noted that there are
notable differences in how and where those injections occurred (predominantly the hand,
neck, or face in that setting), and thus it may not accurately reflect the risk to sharing
injection equipment2122. Current literature specific to transmission among PWID suggests
some conjecture over this figure, likely due to the wide variance in reporting methods

19 Michael G. Hudgens et al., “Estimating the Transmission Probability of Human Immunodeficiency

Virus in Injecting Drug Users in Thailand,” Journal of the Royal Statistical Society: Series C (Applied
Statistics) 50, no. 1 (2001): 1–14, https://doi.org/10.1111/1467-9876.00216.
20 Pragna Patel et al., “Estimating Per-Act HIV Transmission Risk: A Systematic Review,” AIDS 28, no.
10 (June 2014): 1509–19, https://doi.org/10.1097/QAD.0000000000000298.
21 Francesco M. Egro et al., “Seroconversion Rates among Health Care Workers Exposed to Hepatitis
C Virus–Contaminated Body Fluids: The University of Pittsburgh 13-Year Experience,” American
Journal of Infection Control 45, no. 9 (September 1, 2017): 1001–5,
https://doi.org/10.1016/j.ajic.2017.03.011.
22 Fenton M. O’Leary and Timothy C. Green, “Community Acquired Needlestick Injuries in Non-Health
Care Workers Presenting to an Urban Emergency Department,” Emergency Medicine 15, no. 5–6
(2003): 434–40, https://doi.org/10.1046/j.1442-2026.2003.00498.x.
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amongst users. Boelen, et al. found a rate of roughly 0.57%, or 1/175, admitting that the
risk may be as high as 6% per act23. Given the asymptomatic nature of HCV, it stands to
reason that a transmission rate lower than HIV could still result in a far greater number of
total infections and so a conservative estimate may not be as unrealistic as it would
initially appear.

Percent Needles Uncleaned
Definition : The probability that a used needle or syringe was not disinfected bleached
before reuse by a secondary party
Selected Figure : 17%

Bleach has proven to be an effective disinfection measure for injection equipment
and is thus employed regularly for disinfection by PWID24. The low cost and high
effectiveness of bleach led to the mass distribution of “bleach kit” programs long before
more modern needle exchange services were created, which fill of distributing these kits
in many locations across the US. Despite ease of availability, the frequency of effective
disinfection of injection materials is not 100%. While it is reasonable to suggest that SIF
users would likely have a heightened rate of bleaching, it likely be similar to rate among
users of existing NSPs because there would be a large overlap in the types of materials
distributed as well as risk-mitigation education efforts by these respective services.
Previous studies have estimated a percentage of unclean needles used via survey data to
be roughly 17%, or that 83% of the time needles are adequately bleached prior to reuse.25

23 Lies Boelen et al., “Per-Event Probability of Hepatitis C Infection during Sharing of Injecting

Equipment,” PLOS ONE 9, no. 7 (July 7, 2014): e100749,
https://doi.org/10.1371/journal.pone.0100749.
24 Holly Hagan, Enrique R. Pouget, and Don C. Des Jarlais, “A Systematic Review and Meta-Analysis of
Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs,” The Journal of
Infectious Diseases 204, no. 1 (July 1, 2011): 74–83, https://doi.org/10.1093/infdis/jir196.
25 Martin A. Andresen and Neil Boyd, “A Cost-Benefit and Cost-Effectiveness Analysis of Vancouver’s
Supervised Injection Facility,” International Journal of Drug Policy 21, no. 1 (January 1, 2010): 70–76,
https://doi.org/10.1016/j.drugpo.2009.03.004.
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Needles in Circulation
Definition : The number of needles or syringes in circulation amongst the PWID
community, distributed by NSP’s or other available services
Selected Figure : 978,621

Alongside many other states, Michigan has legal provisions supporting the sale of
syringes without prescription at pharmacies and other facilities selling medical supplies,
and as such there is no method of accurately determining whether any syringe sale is
intended for medical or illicit use. This being the case, it’s difficult to ascertain just how
many syringes are in circulation across the entire the PWID community. However this
can be estimated using local NSP data because it can be assumed that procurement
behavior amongst PWID via NSPs and SIFs would be similar, and that their geospatial
reach in terms of needle distribution would be similar.
“Clean Works”, the only NSP operating within Kent County, operates in various
spots surrounding Grand Rapids, Michigan. Clean Works reports roughly 300,000
syringes distributed annually, or roughly 1.501 syringes per person, per year26. Applying
a similar rate to Kent County with regards to the difference in population yields an
approximate estimate of 978,621 syringes distributed across the county. It should be
noted that Clean Works has adopted a system of operating a model unit with a rotating
schedule of locations based on relative PWID demand across different locations within
the city and so while a SIF would provide a similar service, it would presumably be
limited to a static location. In addition, it is assumed that broader Kent County has
roughly the same per capita PWID as the more urban Grand Rapids area, which is a
query that ought be subject to further investigation.

Frequency of Share Events
Definition : The percent likelihood that any instance of injection drug use is a shared
(receptive) injection

26 “Red Project, “Syringe Access, HIV Test, Overdose Prevention”, accessed 23 July, 2019.)
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Selected Figure : 8.00%

Given the high correlation between IDU and communicable diseases, various
social behaviors amongst PWID play a unique and prominent role in viral transmission.
As such, a great deal of data is collected on the frequency of needle-sharing, although this
rate varies amongst study groups and is also notably dependent on the duration any
particular cohort was surveyed. Analysis from interviews of >12,000 individual PWID
yielded a sharing rate of roughly 31.9% in the last thirty days, or up to 64.5% within the
previous six months2728. While it is obvious that the likelihood sharing may have
occurred increases with time, Nguyen et al. worked in conjunction with the CDC to
extrapolate an estimated rate of 8-13% share rate per injection by way of incorporating
reported daily injection averages and share rates across multiple groups across 19 US
cities29.

Number of Sharing Partners
Definition : The average number of individuals injecting in a single assembly or session
Selected Figure : 1.3125

In order to fully characterize patterns of behavior in injection drug use, it is
necessary to consider the number of partners included in any particular session. To
illustrate the relevance of this variable, consider a situation where four individuals in one
setting might share the same set of injection equipment, and the added risk to the fourth
individual to use that set equipment as compared to the second individual (or first, if the
equipment used is not sterile to begin with).

27 Trang Quynh Nguyen et al., “Syringe Exchange in the United States: A National Level Economic

Evaluation of Hypothetical Increases in Investment,” AIDS and Behavior 18, no. 11 (November 2014):
2144–55, https://doi.org/10.1007/s10461-014-0789-9.
28 Shruti H. Mehta et al., “Changes in Blood-Borne Infection Risk Among Injection Drug Users,” The
Journal of Infectious Diseases 203, no. 5 (2011): 587–94.
29 Trang Quynh Nguyen et al., “Syringe Exchange in the United States: A National Level Economic
Evaluation of Hypothetical Increases in Investment,” AIDS and Behavior 18, no. 11 (November 2014):
2144–55, https://doi.org/10.1007/s10461-014-0789-9.

1 Campus Drive • Allendale, MI 49401-9403 • (616) 331-5000

The amount of information on this particular topic is very thin— while there is a
wealth of data supporting the rate of receptive sharing (both over the course of a lifetime
and in say, the last month), this is inadequate to describe the number of individuals
participating in a single exchange. One study found a ratio of roughly 1.3125 receiving to
giving injection equipment in Montreal, Quebec30. This population would have some
overlap with Insite’s clientele base, and represents the more conservative number then
other studies surveying smaller populations or at earlier points in time31. It should be
noted that all known material published on this subject has been collected from NSP’s, so
it is currently unknown whether SIF usage may impact this behavior differently.

Number of SIF Clients
Definition : The annual number of unique visitors to an existing SIF
Selected Figure : 7301 unique, annual clients

In other modeling studies, this figure has been reported as a monthly total of
unique visitors3233. However, there are several issues with this approach. First, any
change in the incidence of HIV or HCV is being reported as cases prevented annually, so
it is more consistent to not convert between differing units of time unnecessarily. In
addition, Vancouver Coastal Health (VCH; the regional state health authority that
includes Vancouver’s DTES and Insite) reported an annual total of 7,301 unique visitors

30 Prithwish De et al., “HIV and HCV Discordant Injecting Partners and Their Association to Drug

Equipment Sharing,” Scandinavian Journal of Infectious Diseases 41, no. 3 (2009): 206–14,
https://doi.org/10.1080/00365540902721376.
31 Amos Irwin et al., “A Cost-Benefit Analysis of a Potential Supervised Injection Facility in San
Francisco, California, USA,” Journal of Drug Issues 47, no. 2 (April 2017): 164–84,
https://doi.org/10.1177/0022042616679829.
32 Amos Irwin et al., “Mitigating the Heroin Crisis in Baltimore, MD, USA: A Cost-Benefit Analysis of a
Hypothetical Supervised Injection Facility,” Harm Reduction Journal 14, no. 1 (12 2017): 29,
https://doi.org/10.1186/s12954-017-0153-2.
33 Amos Irwin et al., “A Cost-Benefit Analysis of a Potential Supervised Injection Facility in San
Francisco, California, USA,” Journal of Drug Issues 47, no. 2 (April 2017): 164–84,
https://doi.org/10.1177/0022042616679829.
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(2017)34. Because some percentage of the first month’s visitors likely returned and are
thus contained within VCH’s reported 7,301 annual unique clients, using one month for
calculation and then converting to an annual unit value is effectively inflating the benefit
of the SIF artificially due to the fact that it is seemingly unlikely that Insite or another SIF
would maintain a consistent standard of roughly 1,700-2,100 unique visitors throughout
the remainder of the year.

SIF Client Reduction in Needle Sharing
Definition : The PWID-reported decrease in injection equipment sharing as a result of
SIF usage or SIF-mediated education initiatives
Selected Figure : 70% reported decrease in needle / syringe sharing

At the heart of any hypothetical model such as this lie some core assumptions that
must be made due to the inherent lack of comparative information. As there are no legally
sanctioned SIFs in the US at this time (much less in the West Michigan area), it is
impossible to say whether a SIF in this area would have a similar impact on individual
behavior as Vancouver’s Insite, or whether that facility would be as well-regarded within
the PWID population in that area. Kerr et al. reported a 70% reduction in sharing at the
Insite facility, a figure that has been reused in modeling for a number of other SIFs 35.
This information was subsequently reviewed independently in meta-analysis, and is thus
accurately representative of Insite’s role36.

34 “Insite User Statistics - Vancouver Coastal Health.” n.d. Accessed June 25, 2019.

http://www.vch.ca/public-health/harm-reduction/supervised-consumption-sites/insite-userstatistics.
35 Thomas Kerr et al., “Safer Injection Facility Use and Syringe Sharing in Injection Drug Users,” The
Lancet 366, no. 9482 (July 2005): 316–18, https://doi.org/10.1016/S0140-6736(05)66475-6.
36 Chloé Potier et al., “Supervised Injection Services: What Has Been Demonstrated? A Systematic
Literature Review,” Drug and Alcohol Dependence 145 (December 1, 2014): 48–68,
https://doi.org/10.1016/j.drugalcdep.2014.10.012.
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Results
Implementation of a SIF in the Kent County area was found to reduce the
frequency of sharing events by roughly 2.5%. The decrease in sharing, subsequently,
would result in a decrease of HCV and HIV incidence attributable to IDU by
approximately 30%. For clarity, as MDHHS report 47 total incident HIV diagnoses were
made in 2017 and only a small percentage of those were due to IDU, this represents a
roughly 5% decrease in HIV diagnoses. With roughly 60% of HCV diagnoses being
associated with IDU, calculations show a flat decrease in 7 incident cases, but the actual
impact of this could vary much more widely due to high transmission of HCV as well as
heightened rates of education and testing services that a SIF could provide to the PWID
community that are difficult to administer currently due to legal and social concerns of
that population. Perhaps most importantly, results here are purely analytical in nature and
would have limited predictability. One especially noteworthy reason for this is that that
drug policy in the US differs significantly from Canada, and developing trust between an
SIF and local PWID is a relationship that would take some time to nurture and mature.

Discussion
While a handful of studies modeling SIFs in the US have been published, there is
still a great deal of work to do with regard to determining best practices. Such studies
have inherent blind spots, and while that is acceptable in the sense that more
comprehensive data is as of yet unavailable, it simultaneously highlights the need for
increased time and resource investment, given the relative success of SIFs north of the
border. At this time, most existing data comes via major metropolitan areas, and the
demand for a broadened tool kit is likely felt most acutely in dense urban environments, it
remains true that lower boundaries of the positive impact of SIFs provides valuable
information to policymakers and a wide assortment of local stakeholders. As such, future
studies would do well to consider the broader implications of SIFs, including impacts on
PWID behavior and third party effects, including those on local health providers, first
responders, and other associated parties.
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Limitations
Given the limited local data available, the results of this test should be considered
subjective and preliminary in nature. While Kent County and Vancouver have similar
population sizes, there is a great difference in population density and this would likely
have a strong impact on PWID attendance and retention with any SIF, which would
ideally be built in the highest concentrated area of need to provide the greatest impact.
Similarly, as Kent County is made of urban, suburban, and rural areas, the per capita
PWID within each geographic subregion is not likely to be consistent and should be
studied more in depth to help define those areas of greatest need. Finally, it is
questionable whether a Kent County SIF would result in a similar reduction on injection
equipment sharing.
On the opposing side, this study also does not detail a comprehensive list of
changes that may occur with the addition of a SIF. Most notably, SIFs have also shown to
decrease drug overdoses, and soft skin and tissue infections that are also extremely
common amongst injection drug users. Other benefits may also include decreases in
hospital bed stay and first responder expenses, both of which are also often absorbed by
the general tax base. SIFs and NSPs would also impact biohazard waste, decreasing the
amount of used drug supplies discarded in public areas, decreasing risk to others and
helping maintain clean urban environments.
In addition to those mentioned above, future studies could improve this test with
further localization of data. The rate of equipment sharing, number of sharing partners,
likelihood of bleaching shared equipment, and number of needles in circulation are all
specific to differing populations and are impacted by outside confounders (such as the
local economy or job market), and with significant ethical considerations in place this
information could be surveyed anonymously via local NSPs. Ideally, surveys would be
completed at multiple points in time or over long periods in order to produce large
averages or detect changes in behavioral patterns over time within a given survey area.
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